Organ Engineer Cleared of Misconduct

The Karolinska Institute has rejected the conclusions of an earlier, independent investigation, finding regenerative medicine researcher Paolo Macchiarini not guilty of scientific misconduct.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

An artificial trachea, similar to those transplanted by Macchiarini, made by seeding an inorganic scaffold with stem cellsUCLThe long and winding saga of Paolo Macchiarini got another twist last week: the Karolinska Institute—where he has served as a visiting professor for several years—has found the artificial organ pioneer not guilty of scientific misconduct allegations made by colleagues years ago. On Friday (August 28) Anders Hamsten, vice chancellor of the institute, released a report clearing Macchiarini of misconduct in the cases of three patients who Macchiarini implanted with artificial tracheae—two of whom died. In May, independent investigator Bengt Gerdin of Uppsala University in Sweden, found Macchiarini guilty of misrepresenting key aspects of papers describing the surgical procedures such that readers were misled into thinking they were more successful than they actually were. “There were data in the papers that could not be found in the medical records,” Gerdin told ScienceInsider in May. The discrepancies constitute “a systemic misrepresentation of the truth that lead the reader to have a completely false impression of the success of the technique,” he said.

But the new report—performed by Karolinska officials and bolstered by new information provided by Macchiarini and others “that is critical to how the complaint is assessed,” according to Hamsten—rejects Gerdin’s findings, and clears the thoracic surgeon of wrongdoing in the cases.

Macchiarini told The New York Times that he was relieved that the Karolinska investigation exonerated him and that “justice has finally been done.” He said that the accusations against him were “extremely damaging: to me, to my team and to the whole field of regenerative medicine.”

But Macchiarini isn’t getting off scot-free. The Karolinska report mentioned that “certain circumstances that have arisen during the inquiry concerning Professor Macchiarini’s work show, however, that it does not meet the university’s high quality standards in every respect.” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies